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Background: Absolute cardiovascular risk assessment (CVRA) is based on the com-
bined effects of multiple risk factors and can identify asymptomatic individuals at high 
risk of cardiovascular disease (CVD). Aboriginal and Torres Strait Islander people, the 
Indigenous people of Australia, are disproportionately affected by CVD and diabetes. 
Our study aimed to investigate variations in the use of absolute CVRA in patients with 
diabetes at Indigenous community healthcare centers and to identify patient and health 
center characteristics that may contribute to this variation.
Methods: Audits of clinical records of 1,728 patients with a known diagnosis of diabetes 
across 121 health centers in four Australian States/Territories [Northern Territory (NT), 
South Australia, Western Australia, and Queensland] over the period 2012–2014 were 
conducted as part of a large-scale continuous quality improvement program. Multilevel 
regression modeling was used to quantify variation in recording of CVRA attributable to 
health center and patient characteristics.
results: The proportion of eligible patients with documented CVRA was 33% 
(n = 574/1,728). The majority (95%) of assessments were conducted in the NT. Multilevel 
regression analysis showed health center characteristics accounted for 70% of the vari-
ation in assessments in the NT. Government-operated health centers had 18.8 times the 
odds (95% CI 7.7–46.2) of recording CVRA delivery compared with other health centers.
conclusion: Health centers in the NT delivered the majority of absolute CVRA to Indigenous 
patients with diabetes in our study. Health systems factors that may have facilitated provi-
sion of CVRA in the NT include decision support tools and a reporting process for CVRA 
delivery. Implementation of similar systems in other jurisdictions may help improve CVRA 
delivery. Early identification and treatment of high risk individuals through wider use of 
CVRA may help reduce the burden of CVD in Indigenous Australians with diabetes.
Keywords: absolute cardiovascular risk assessment, indigenous, diabetes, audit, quality improvement, primary 
health care
Abbreviations: ABCD, audit and best practice for chronic disease; CARPA, Central Australian Rural Practitioner’s Association; 
CCMM, chronic conditions management model; CKD, chronic kidney disease; CQI, continuous quality improvement; CVD, 
cardiovascular disease; CVRA, cardiovascular risk assessment; NHMRC, National Health and Medical Research Council; NT, 
Northern Territory; NTG, Northern Territory government; NVPDA, National Vascular Disease Prevention Alliance; PCIS, 
primary care information system.
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inTrODUcTiOn
Absolute cardiovascular risk assessment (CVRA) provides an 
assessment of cardiovascular risk based on the effects of a com-
bination of risk factors. CVRA helps identify individuals who are 
asymptomatic but at high risk of cardiovascular disease (CVD), 
including stroke, transient ischemic attack, myocardial infarction, 
peripheral arterial disease, and heart failure (1). Early identifica-
tion of individuals at high risk of CVD (>15% risk of CVD within 
the next 5 years) using CVRA can enable effective management 
of modifiable risk factors, including lifestyle changes, pharmaco-
therapy, and improvement of CVD-related clinical targets (1–8). 
CVRA and targeted treatments are cost-effective and have the 
potential to reduce the burden of CVD (9, 10).
Globally, CVD is the leading cause of death and imposes a sub-
stantial social and economic burden at population and household 
levels (9, 11). Socioeconomically disadvantaged populations, 
including Indigenous peoples, have a disproportionate burden 
of CVD and risk factors of CVD, including diabetes (12–14). 
In Aboriginal and Torres Strait Islander people, the Indigenous 
people of Australia, CVD and diabetes, respectively, account for 
27 and 8% of deaths (15). CVD and Type 2 diabetes also account 
for 23 and 12%, respectively, of health gaps between Indigenous 
and non-Indigenous Australians (16). Preventive efforts target-
ing modifiable risk factors for both CVD and diabetes offer 
significant opportunity to improve Indigenous health in Australia 
and internationally (12–14, 16). A recent National Health and 
Medical Research Council (NHMRC) document on improving 
performance in the management of CVD in Australian hospitals 
noted that significant improvements in cardiovascular health care 
delivery are possible, including provision of preventive services 
such a CVRA to Aboriginal and Torres Strait Islander people (17).
The National Vascular Disease Prevention Alliance (NVDPA) 
recommends the Framingham Risk Equation (derived from the 
Framingham Heart Study) be used to calculate absolute CVD risk 
and includes age, sex, systolic blood pressure, smoking status, total 
cholesterol, HDL cholesterol, diabetes, and electrocardiogram 
evidence of left ventricular hypertrophy in CVRA calculations 
(1). NVPDA recommends that “adults with diabetes who are 
60 years or less” without known CVD or increased risk of CVD 
should receive absolute CVRA at least every 2 years depending 
on the level of risk of CVD (1). Although the Framingham Risk 
Equation has been found to underestimate risk in Aboriginal and 
Torres Strait Islander people and in people with diabetes, absolute 
CVRA using the Framingham risk equation is a more accurate 
predictor of future vascular events for these populations than any 
single CVD risk factor alone (1, 18, 19).
The use of absolute CVRA in the primary care setting for 
Aboriginal and Torres Strait Islander people with diabetes has 
not been previously reported. Previous studies have been limited 
to assessment of individual risk factors and the measures taken 
to address these risk factors (20–23). The aim of our study is to 
investigate the delivery of absolute CVRA in patients with Type 
2 diabetes attending Indigenous primary healthcare services 
between 2012 and 2014 and to identify the influence of health 
center and individual patient level factors on the delivery of 
absolute CVRA.
MaTerials anD MeThODs
From 2002, the Audit and Best Practice for Chronic Disease 
(ABCD) project has been operating across several jurisdictions 
and aims to investigate variation in and to improve the quality 
of care in a range of priority areas in Indigenous primary care, 
including chronic diseases, maternal health, and child health. 
From 2010, One21seventy, a not-for-profit entity, continued 
the service support for continuous quality improvement (CQI) 
to over 200 Indigenous health centers (24). These health cent-
ers use clinical audit tools developed by the Menzies School 
of Health Research to assess recording of service delivery and 
quality of service provision. One hundred and seventy of these 
services have voluntarily provided their de-identified audit 
data to the ABCD National Research Partnership for research 
of variation in quality of care, barriers, and strategies for 
improvement.
This study used the ABCD/One21seventy Type 2 diabetes 
audit dataset. This dataset included records of participating 
health centers’ delivery of recommended services for patients 
with Type 2 diabetes. Of 170 Aboriginal and Torres Strait 
Islander community health centers participating in the ABCD 
National Research Partnership, 121 health centers in four states 
and territories audited clinical records to assess the quality of 
Type 2 diabetes care between January 2012 and December 2014. 
For the participating community health centers, the records of 
Indigenous patients who met the following criteria were eligible 
for audit: (1) A definite diagnosis of Type 2 diabetes according 
to health center records; (2) aged 15  years and above; and (3) 
lived in the community for 6 months or more in the last year. 
Residence in the community for ≥6 months in the last year was 
determined by examining health center records and discussions 
with Aboriginal and/or Torres Strait Islander Health Workers/
Practitioners familiar with the community.
From December 2011, the diabetes audit tool included 
a question on CVRA delivery, “Is there a record that an 
absolute CVR assessment has been performed within the last 
12 months?” (25). The audit protocol specified that there needed 
to be a clear record that a CVRA had been completed. While a 
record of a statement such as “CVRA done” was sufficient to 
satisfy this requirement, there was also usually a record of level 
of risk. To determine current status of absolute CVRA delivery, 
records from the most recent Type 2 diabetes audit between 
2012 and 2014 from each health center were included. Data 
were abstracted by health center staff using standard protocols 
and who had been trained in the use of ABCD/One21seventy 
audit tools, with support from quality improvement facilitators 
and One21seventy staff.
We excluded records of patients greater than 60 years of age 
in line with the NVDPA recommendations (1, 26). Patients with 
chronic heart disease, congestive heart failure, systolic blood 
pressure greater than 180  mmHg, or diastolic blood pressure 
greater than 110 mm Hg and previous acute myocardial infarc-
tion were excluded from the study because they have clinically 
determined high risk of CVD (1). Patients with estimated glo-
merular filtration rate (eGFR) less than 45 mL/min/1.73 m2 have 
clinically determined high risk of CVD (1). Categories of eGFR 
FigUre 1 | enrollment of aboriginal and Torres strait islander 
patients with Type 2 diabetes into the study.
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included in the audit tool were ≥60 mL/min/1.73 m2, 30–59 mL/
min/1.73 m2, 15–29 mL/min/1.73 m2, <15 mL/min/1.73 m2, and 
“no record.” As <45 mL/min/1.73 m2 was not specifically included 
as a category of eGFR in the audit tool, we excluded patients with 
eGFR <60 mL/min/1.73 m2 because of likely high CVD risk.
Health center characteristics included in the audit tool were 
size of service population, type of health center (community con-
trolled or government operated), CQI experience, and location 
based on the Australian Standard Geographical Classification 
System (very remote, remote or non-remote). The classification 
of remoteness is based on the physical distance of a populated 
locality to the nearest urban center and reflects access to goods 
and services (27). Patients were excluded from the analysis if they 
did not attend the health center over the past 12  months or if 
CVRA was recorded as “not due.”
The audit records included the following patient-level char-
acteristics: age, sex, documented comorbid conditions, and 
complications. Hypertension, dyslipidemia, chronic obstructive 
pulmonary disease (COPD), chronic kidney disease (CKD), 
depression, and other mental illness were each recorded as pre-
sent or absent. Similarly, complications of diabetes (retinopathy, 
neuropathy, foot ulcer, amputation, and gastroparesis) were 
recorded as present or absent.
Ethics approval was obtained from research ethics commit-
tees in each jurisdiction: Human Research Ethics Committee 
of the Northern Territory Department of Health and Menzies 
School of Health Research (HREC-EC00153); Central 
Australian Human Research Ethics Committee (HREC-12-
53); Queensland Human Research Ethics Committee Darling 
Downs Health Services District (HREC/11/QTDD/47); South 
Australian Aboriginal Health Research Ethics Committee (04-
10-319); Curtin University Human Research Ethics Committee 
(HR140/2008); Western Australian Country Health Services 
Research Ethics Committee (2011/27); Western Australia 
Aboriginal Health Information and Ethics Committee (111-
8/05); and University of Western Australia Human Research 
Ethics Committee (RA/4/1/5051).
statistical analysis
Our data had a multilevel dependency structure, with indi-
vidual patients clustered within health centers and health centers 
clustered within jurisdictions. Multilevel mixed effects logistic 
regression analysis was used to quantify variation in the delivery 
of absolute CVRA attributable to health center and patient level 
characteristics. We calculated unadjusted odds ratios to measure 
the unadjusted association between dependent and independ-
ent variables. All variables, including non-significant variables, 
were included in further analyses. In a hierarchical approach, 
we included health center variables (Model A) and then patient 
variables (Model B). The amount of variation due to introduction 
of the different groups of variables in the models was determined 
by the proportional change in variance at different levels. Because 
CVRA delivery outside the Northern Territory (NT) was 
limited, we restricted our analysis to this jurisdiction and com-
pared results to the same analysis for the NT and other states. 
A p value ≤0.05 was considered significant. We completed 
statistical analyses with STATA software, version 14.
Sensitivity Analyses
We evaluated the inclusion of patients with CKD and eGFR 
greater than 60 mL/min/1.73 m2, that is separate analyses were 
conducted for datasets including (1) patients with CKD and 
eGFR greater than 60 mL/min/1.73 m2 and (2) patients with no 
evidence of CKD or eGFR greater than 60 mL/min/1.73 m2.
resUlTs
The participating health centers had 2,389 clinical records for 
Indigenous patients with Type 2 diabetes between 15 and 60 years 
of age. The records for 1,728 patients met the inclusion criteria 
for the study (Figure 1). There was wide variation in delivery of 
absolute CVRA across jurisdictions (Table  1). In the NT, 56% 
of eligible patients received CVRA, compared to 3% in other 
jurisdictions. The majority (95%) of assessments were conducted 
in the NT.
Of the 52 participating health centers in the NT, 87% were 
located in very remote areas, 52% had a service population of 
500 or fewer, and 77% were government operated (Table 2). The 
proportion of government and community-controlled health 
centers were estimated to be 76 and 52%, respectively, of total 
government and community-controlled health centers in the NT. 
Eight hundred and seventy seven patients (89%) from the NT were 
between 30 and 60 years of age (Table 2). Sixty-two percent of 
TaBle 1 | number and percentage of patients who received absolute 
cVra in participating health centers between 1 January 2012 and  
31 December 2014 in the northern Territory and other jurisdictions.
state number of patients who received 
absolute cVra (percentage of 
eligible patients in state)
Total number 
of eligible 
patients
number 
of health 
centers
Northern 
Territory
548 (56) 984 52
Other 
jurisdictionsa
26 (3) 744 69
Total 574 (33) 1,728 121
aOther jurisdictions include Queensland, South Australia, and Western Australia.
TaBle 2 | health center and patient characteristics of participating health centers in the northern Territory and other jurisdictions between 1 January 
2012 and 31 December 2014.
characteristic northern Territory Other jurisdictions
Total number of 
health centers/
patients
number of patients recorded as 
receiving cVra (percentage in 
brackets)
Total number of 
health centers/
patients
number of patients recorded 
as receiving cVra (percentage 
in brackets)
health center (N = 121)
Location Non-remote 2 9 (32) 15 10 (7)
Remote 5 102 (61) 5 2 (6)
Very remote 45 437 (55) 49 14 (2)
Type of health center Community-controlled 12 64 (24) 8 2 (2)
Government 40 484 (68) 61 24 (4)
Service population ≤500 27 263 (64) 28 13 (5)
501–999 10 119 (56) 16 2 (1)
≥1000 15 166 (47) 25 11 (4)
CQI experience Nil previous cycles 3 44 (50) 10 5 (7)
1–2 previous cycles 23 285 (66) 33 6 (2)
≥3 previous cycles 26 219 (47) 26 15 (4)
Patient (N = 1,728)
Age group 15 to <30 107 50 (47) 43 2 (5)
30 to <45 434 240 (55) 244 6 (2)
45–60 443 258 (58) 457 18 (4)
Sex Male 375 200 (53) 313 9 (3)
Female 609 348 (57) 431 17 (4)
Comorbidities Hypertension 338 204 (60) 312 15 (5)
COPD 126 66 (52) 89 4 (4)
Dyslipidemia 502 285 (57) 365 12 (3)
CKD 327 211 (65) 59 1 (2)
Depression 51 25 (49) 56 3 (5)
Other mental illness 43 22 (51) 39 2 (5)
Complications Retinopathy 36 22 (61) 64 2 (3)
Neuropathy 40 16 (40) 36 1 (3)
Foot ulcer 14 9 (64) 23 1 (4)
Amputation 11 7 (64) 5 0 (0)
Gastroparesis 6 0 (0) 13 0 (0)
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patients were females. Fifty-one percent of patients were recorded 
as having dyslipidemia. Diabetic neuropathy was the most com-
mon complication of diabetes and was recorded for 4% of patients.
The strongest predictor of CVRA delivery was location of health 
center in the NT. (Table A1 in Supplementary material). For the NT, 
unadjusted logistic regression showed that government-operated 
health centers were more likely to record delivery of CVRA than 
other health centers (unadjusted odds ratio 13.6, 95% confidence 
interval 6.1–30.5). In the adjusted analysis (Model A), the asso-
ciation between government-operated health centers and CVRA 
delivery increased (OR 21.0, 95% CI 8.7–50.4). Remote location 
was also associated with provision of CVRA (OR 12.3, 95% CI 
1.6–93.5) in Model A. The proportional change in variance from 
the unadjusted model to Model A showed that health center fac-
tors explained 70% of variation in the administration of absolute 
CVRA across health centers in the NT (Table  3). The addition 
of patient level variables did not appreciably explain further 
variation in CVRA. Remote location (OR 13.0, 95% CI 1.6–103.7), 
government-operated health centers (OR 18.8, 95% CI 7.7–46.3), 
and female gender (OR 1.5, 95% CI 1.1–2.1) were significantly 
associated with CVRA delivery in Model B.
sensitivity analyses
When patients with CKD and eGFR greater than 60 mL/min/1.73 m2 
were excluded, predictors of CVRA delivery were similar to the 
results described above. (Table A2 in Supplementary material)
TaBle 3 | Unadjusted and adjusted multilevel regression analysis of health center and patient level characteristics on recording of absolute cVra for 
patients with diabetes in participating health centers in the northern Territory between 1 January 2012 and 31 December 2014 (n = 52 health centers; 
984 patient records).
Predictors Unadjusted odds ratio empty 
model
Model a – health center 
characteristics only
Model B – health center and 
patient characteristics
UOr 95% ci p value Or 95% ci p value Or 95% ci p value
health center characteristics
Location Non-remote 1 (Base) 1 (Base) 1 (Base)
Remote 2.96 0.20–43.52 0.428 12.38 1.64–93.48 0.015a 12.98 1.63–103.66 0.016a
Very remote 2.43 0.23–25.76 0.460 1.77 0.31–10.28 0.524 1.61 0.26–9.84 0.604
Type of health 
center:
Community 
controlled
1  (base) 0.000a 1 (base) 0.000a 1 (base) 0.000a
Government 13.63 6.09–30.54 19.67 8.21–47.16 18.84 7.67–46.29
Service 
population
≤500 1 (base) 1 (base) 1 (base)
501–999 0.62 0.20–1.90 0.402 2.03 0.88–4.73 0.099 2.07 0.88–4.90 0.228
≥1000 0.38 0.14–1.02 0.555 0.66 0.32–1.36 0.258 0.65 0.31–1.38 0.262
CQI experience Nil previous cycles 1 (base) 1 (base) 1 (base)
1–2 previous cycles 2.57 0.40–16.38 0.318 1.11 0.31–3.95 0.876 1.07 0.29–3.88 0.924
≥3 previous cycles 1.01 0.16–6.33 0.991 1.10 0.32–3.82 0.877 1.06 0.30–3.76 0.928
Patient characteristics
Sex Male 1 (base) 1 (base) 0.019a
Female 1.40 1.01–1.93 0.038a 1.49 1.07–2.07
Age group 15 to <30 1 (base) 1 (base)
30 to <45 1.19 0.71–2.00 0.512 1.14 0.67–1.94 0.629
45–60 1.40 0.83–2.35 0.210 1.34 0.77–2.32 0.306
Comorbiditiesb Hypertension 1.08 0.77–1.51 0.659 0.94 0.65–1.36 0.738
COPD 0.90 0.56–1.44 0.663 0.85 0.52–1.36 0.490
Dyslipidemia 1.22 0.89–1.68 0.218 1.25 0.89–1.76 0.197
CKD 1.41 0.99–2.00 0.059 1.29 0.89–1.86 0.178
Depression 0.82 0.40–1.65 0.573 0.87 0.41–1.84 0.723
Other mental illness 0.64 0.30–1.35 0.241 0.66 0.30–1.45 0.305
Complicationsb Retinopathy 1.06 0.47–2.42 0.886 0.98 0.42–2.27 0.960
Neuropathy 0.69 0.32–1.48 0.336 0.70 0.32–1.55 0.379
Foot ulcer 2.07 0.52–8.22 0.301 2.26 0.54–9.43 0.261
Amputation 1.51 0.28–8.00 0.629 1.44 0.27–7.64 0.666
Gastroparesisc 1 (Empty) 1 (Empty)
Random effects 
(intercepts)
Variance (SE) 2.22 (0.58) 0.66 (0.22) 0.69 (0.23)
Proportional change 
in variance
70.09% 68.86%
aStatistically significant.
bComorbidities and complications were compared with patients without the specific comorbidity or complication, such that an odds ratio of 1 relates to not having the specific 
comorbidity or complication.
cThe six patients with gastroparesis had no recorded CVRA.
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DiscUssiOn
Our study found wide variation in the delivery of absolute CVRA 
across jurisdictions over the study period. The majority (95%) 
of assessments were conducted in the NT. Health center factors 
accounted for 70% of the variation in CVRA delivery in the NT. 
Factors associated with increased recording of CVRA delivery 
were government-operated health centers, remote health centers, 
and female gender (Model B, Table 3).
Men represented 38% of eligible patients in the NT and were 
less likely to receive CVRA than women. While fewer Aboriginal 
and Torres Strait Islander men than women report a diagnosis of 
diabetes (7.3% compared to 8.9%) (28), they also access preventive 
health services less often than women (29, 30). Poor health seek-
ing among men results in poor use of health services and limited 
opportunities for access to health information, promotion, and 
preventive care. Further research is required to better understand 
how to deliver preventive health services and gender-appropriate 
healthcare to men (29).
Consistent with other studies, we found gaps in record-
ing absolute cardiovascular risk (6, 19, 31). The Treatment 
of Cardiovascular Risk using Electronic Decision Support 
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(TORPEDO) study recorded relatively high levels of CVRA. In 
this study, 30 primary healthcare centers in Queensland and 
New South Wales were randomized to receive a computer-
guided quality improvement intervention, and 30 centers were 
randomized to usual care. At intervention sites, 63% of eligible 
patients received appropriate CVD screening compared to 53% 
of patients attending non-intervention sites (RR 1.25; 95% CI 
1.04–1.50; p =  0.02) (32). In the Kanyini Audit, 53% of 1,165 
randomly selected case records of adults attending Indigenous 
health centers lacked information for one or more Framingham 
risk variables. Screening and management gaps were similar 
to those found in non-Indigenous health settings, suggesting 
a need for improvement across the health system (19). Despite 
similarities in the gaps in screening, ongoing disparities in car-
diovascular risk and complications persist between Indigenous 
and non-Indigenous Australians (16, 22). Absolute CVRA may 
help reduce these disparities by encouraging early detection and 
intervention for Indigenous adults at high risk of CVD (6, 22).
There are a number of possible explanations for relatively 
high delivery of CVRA in government-operated health centers 
in the NT. First, Burgess et al.’s study of CVRA in Arnhem Land 
in 2005 showed that CVRA during the adult health check may 
contribute to better and earlier detection of cardiovascular risk 
and population reductions in cardiovascular risk (6). These find-
ings led to the incorporation of CVRA into the Central Australian 
Rural Practitioner’s Association (CARPA) Manual (33). Second, 
following the study in Arnhem Land, CVRA was promoted in 
Preventable Chronic Disease Strategy Workshops in the NT in 
2006–2007. Primary care providers participating in the workshop 
received education about the utility of CVRA in the adult health 
check (34). Chronic care educators and CQI facilitators have 
continued to provide outreach support to primary care providers 
to implement CVRA. Third, following the commencement of 
the Chronic Conditions Management Model (CCMM) in 2012, 
Northern Territory Government (NTG) health services received 
regular feedback about (i) the proportion of Indigenous patients 
aged >20 years who received CVRA, (ii) gaps between screen-
ing and initiating treatment to allow patients who are missing 
care to be identified and recalled, and (iii) achieving targets for 
modifiable risk factors for individuals identified at high risk of 
CVD. Burgess et al. found that implementation of CCMM led to 
improvements in NT population coverage of CVRA from 23% in 
mid-June 2012 to 58.5% in August 2014 (8). Introducing similar 
auditing processes and national CVRA-related key performance 
indicators may improve CVRA delivery in other jurisdictions.
Wide-scale CVRA can be supported by including a user-
friendly CVRA calculator in clinical information systems. 
For example, the computer-guided decision support tool in 
the TORPEDO study improved CVD risk measurement. The 
absence of an electronic CVRA calculator has been identi-
fied as a barrier to CVRA delivery in primary care settings 
(35). Community-controlled health centers in the NT have 
campaigned for incorporation of a CVRA calculator in clinical 
information systems but this is not yet available. As a result, 
clinicians calculate CVRA manually. Lack of access to such a 
tool may contribute to underreporting of CVRA in community-
controlled health centers in the NT.
There is contention about the usefulness of CVRA in 
Aboriginal and Torres Strait Islander people and people with dia-
betes because the Framingham risk equation can underestimate 
risk in these populations (1, 18). To date, no studies have been 
published evaluating adjustments for Indigenous Australians 
that are similar to adjustments for Maori, Pacific Islander, and 
Indian patients recommended in New Zealand guidelines (6, 36). 
While further work is required to develop accurate CVD risk 
estimates for Indigenous Australians, adjustments included in 
the CARPA Manual risk calculators may provide a more reliable 
estimate of CVD risk than the Framingham risk equation (6, 33). 
Further research is also required to assess whether CVRA leads to 
improved clinical outcomes in Indigenous people with diabetes.
The strength of this study is the inclusion of 76% of NT gov-
ernment-operated services and 52% of community-controlled 
health services in this study. As a significant proportion of NT 
health services are included in this audit, the results are likely to 
be generalizable to the NT, and perhaps to a more limited extent 
to other jurisdictions. The age groups of patients included in the 
study are similar to the age groups for which Aboriginal and 
Torres Strait Islander adult health checks are recommended (aged 
15 years and over but under the age of 55 years) (37). Our study 
assessed delivery of CVRA in regular residents in the community 
(i.e., individuals who had lived in the community for at least six 
of the past 12 months) as visitors or short-term residents of the 
community may not be regarded by health center staff as being 
within the priority target group for preventive care.
The main limitations of this study are (1) potential partici-
pation bias as only community health centers that participated 
in the One21seventy clinical audit cycles were included in the 
study. For example, the TORPEDO study found relatively high 
levels of CVRA in community controlled health services in 
Queensland (32). Less than 5% of community controlled health 
services in Queensland participated in this study. (2) The study 
relied on patient records to abstract information about CVRA. 
Under-documentation may result in underestimation of service 
delivery and contribute to over-servicing, inefficiency and poor 
coordination and continuity of patient care. However, clear, accu-
rate documentation is essential for coordinating health service 
delivery (23). (3) Clinical audits were carried out by multiple data 
abstractors and inter-rater reliability was not formally assessed 
in this study. Although inter-rater reliability was satisfactory 
in previous studies that used similar audit forms (23, 38), it is 
possible that manual CVRA calculations may have been missed. 
(4) The ABCD audit protocol did not record total cholesterol 
>7.5 mmol/L, familial hypercholesterolemia, microalbuminuria, 
or eGFR <45 mL/min/1.73 m2. Adjustments to the audit protocol 
may improve detection of these patients with clinically deter-
mined high risk of CVD in future studies.
While the clinical audit included information on the date of 
diagnosis of diabetes, in many cases there was not a clear record 
of date of diagnosis. We therefore included all patients with a diag-
nosis of diabetes, regardless of the date of diagnosis. There may 
therefore be a small proportion of patients who may have been 
diagnosed so recently that the period between the diagnosis and 
the date of the audit may have been so short that it would not be 
reasonable to expect that some of the scheduled services specified 
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in the audit tool would have been delivered. The same approach 
was applied in all audits, and so comparisons between groups are 
unlikely to be affected. The proportion of patients affected is also 
likely to be too small to have made a meaningful impact on the 
findings. Despite limitations of the audit method, the study pro-
vides valuable guidance for policy, practice and further research.
cOnclUsiOn
In conclusion, we found wide variation in the delivery of CVRA 
across jurisdictions in our study. The NT delivered the majority of 
CVRA to Aboriginal and Torres Strait Islander patients with dia-
betes. Health center characteristics accounted for the majority of 
variation in CVRA delivery. A number of health systems factors, 
including the electronic CVRA calculator and the CCMM, may 
have facilitated delivery of this service. Further understanding 
of the impact of CVRA on the clinical outcomes of Aboriginal 
and Torres Strait Islander people with diabetes may provide 
additional guidance to clinicians and policy makers. Efforts to 
improve early identification and treatment of high risk individu-
als in the primary care setting may play a critical role in reducing 
the burden of CVD in Indigenous Australians with diabetes.
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